Skip to main content

CORRECTION article

Front. Public Health, 11 January 2024
Sec. Disaster and Emergency Medicine
Volume 11 - 2023 | https://doi.org/10.3389/fpubh.2023.1359708

Corrigendum: High perceived stress in patients on opioid agonist therapies during rapid transitional response to the COVID-19 pandemic in Ukraine

This article is a correction to:

  1. High perceived stress in patients on opioid agonist therapies during rapid transitional response to the COVID-19 pandemic in Ukraine

    1. Read original article
\r\nSamy J. GalvezSamy J. Galvez1Frederick L. Altice,,Frederick L. Altice1,2,3Anna Meteliuk Anna Meteliuk4*Roman IvasiyRoman Ivasiy1Eteri MachavarianiEteri Machavariani1Scott O. FarnumScott O. Farnum3Tetiana FomenkoTetiana Fomenko4Zahedul IslamZahedul Islam4Lynn M. Madden,Lynn M. Madden1,3
  • 1Yale School of Medicine, Section of Infectious Diseases, New Haven, CT, United States
  • 2Division of Epidemiology of Microbial Diseases, Yale School of Public Health, New Haven, CT, United States
  • 3APT Foundation, New Haven, CT, United States
  • 4Alliance for Public Health of Ukraine, Kyiv, Ukraine

A corrigendum on
High perceived stress in patients on opioid agonist therapies during rapid transitional response to the COVID-19 pandemic in Ukraine

by Galvez, S. J., Altice, F. L., Meteliuk, A., Ivasiy, R., Machavariani, E., Farnum, S. O., Fomenko, T., Islam, Z., and Madden, L. M. (2023). Front. Public Health 11:1231581. doi: 10.3389/fpubh.2023.1231581

In the published article, there was an error in the affiliations.

Instead of “3Alliance for Public Health of Ukraine, Kyiv, Ukraine

4APT Foundation, New Haven, CT, United States”,

it should be “3APT Foundation, New Haven, CT, United States

4Alliance for Public Health of Ukraine, Kyiv, Ukraine”.

In the published article, there was an error regarding the affiliations for Lynn M. Madden.

As well as having affiliation 3APT Foundation, New Haven, CT, United States, they should also have 1Yale School of Medicine, Section of Infectious Diseases, New Haven, CT, United States.

The authors apologize for this error and state that this does not change the scientific conclusions of the article in any way. The original article has been updated.

Publisher's note

All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.

Keywords: opioid agonist therapies, methadone, buprenorphine, stress, COVID-19, Ukraine

Citation: Galvez SJ, Altice FL, Meteliuk A, Ivasiy R, Machavariani E, Farnum SO, Fomenko T, Islam Z and Madden LM (2024) Corrigendum: High perceived stress in patients on opioid agonist therapies during rapid transitional response to the COVID-19 pandemic in Ukraine. Front. Public Health 11:1359708. doi: 10.3389/fpubh.2023.1359708

Received: 21 December 2023; Accepted: 28 December 2023;
Published: 11 January 2024.

Approved by:

Frontiers Editorial Office, Frontiers Media SA, Switzerland

Copyright © 2024 Galvez, Altice, Meteliuk, Ivasiy, Machavariani, Farnum, Fomenko, Islam and Madden. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.

*Correspondence: Anna Meteliuk, bWV0ZWxpdWsmI3gwMDA0MDthcGgub3JnLnVh

Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.